Routes of
administration By mouth CAS Number 154039-60-8 IUPHAR/BPS 5220 | ATC code None PubChem CID 119031 Molar mass 331.408 g/mol | |
 | ||
Legal status Development terminated? | ||
Marimastat was a proposed antineoplastic drug developed by British Biotech. It acted as a broad-spectrum matrix metalloproteinase inhibitor.
Marimastat performed poorly in clinical trials, and development was terminated.
References
Marimastat Wikipedia(Text) CC BY-SA